Navigation Links
SpineFrontier's® First SacroFUSE® and NanoFUSE Case Performed in Latin America
Date:2/22/2019

On January 7th, 2019, Neurosurgeons Dr. Mario Cahueque and Dr. Enrique Azmitia implanted SpineFrontier’s SacroFuse system in conjunction with NanoFUSE’s Orthobiologic during a surgery at the Hospital Centro Medico in Guatemala City, Guatemala. The case represents the first time that either SacroFuse or NanoFUSE have been used in Latin America.

Dr. Cahueque performed a sacroiliac arthrodesis for sacroiliac dysfunction in a 70-year old male that had been suffering lower back pain for over a year. Sacroiliac pain and dysfunction is a frequent pathology especially in patients with lumbar fusion. Until the surgery date, the patient was receiving a conservative treatment with intra-articular injections and physical therapy.

Dr. Cahueque used three SacroFuse screws to fuse the sacroiliac joint. The SacroFuse is an innovative Less Exposure Surgery (LES™) technology designed to leverage the familiarity of existing techniques while minimizing tissue disruption. The fusion was enhanced by the NanoFUSE Orthobiologic, which is the only FDA-cleared, biologic combination of Demineralized Bone Matrix (DBM) plus Bioactive Glass.

Dr. Cahueque reported that the patient has made an excellent recovery. He believes this first case in Guatemala is significant. “This new less invasive treatment opens new options for the treatment of this pathology for patients with chronic sacroiliac joint pain,” Dr. Cahueque said. He has already planned his next SacroFuse/NanoFUSE case and is grateful for the support of Francisco Gramajo of Moalconver who helped make the SacroFuse surgery in Guatemala possible.

About SpineFrontier Inc.

SpineFrontier is a growing medical device technology company that designs and develops implants and instruments for spine surgery, based on the Less Exposure Surgery (LES) philosophy. These technologies and techniques are designed to allow for outpatient surgery due to minimal disruption of normal tissue. SpineFrontier is headquartered in Malden, Mass. It is a KICVentures portfolio company and the leader in LES technologies.

About NanoFUSE Biologics

NanoFUSE is the synergistic blend of osteoinductive DBM combined with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in all orthopedic surgery. NanoFUSE Biologics is a KICVentures portfolio company, distributed by SpineFrontier.

About KICVentures
KICVentures is a private investment company founded in 2005 by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities. It is the parent company of NanoFUSE and SpineFrontier and is headquartered in Boston, Mass.

Read the full story at https://www.prweb.com/releases/spinefrontier_s_first_sacrofuse_and_nanofuse_case_performed_in_latin_america/prweb16113036.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Valencell and Sonion Demo First Ever Hearing Aid Receiver in Canal with Embedded Biometric Sensor
2. Kansas City Men’s Clinic First to Launch Revolutionary PulseEd™
3. Superior Controls - First Company Globally to Achieve CSIA Certification for the Seventh Consecutive Time
4. Prominent Stevia Leaders Win First Ever James A. May Father of Stevia Awards at Global Conference
5. PolyU Dean of Faculty of Construction and Environment - First in Hong Kong Awarded International Accolade in Wind Engineering
6. Istituto Italiano di Tecnologia (IIT) and Movendo Technology Launch the Production of their First 30 Rehabilitative Hunova Robots
7. Ram Group Announces Worlds First Full-Body Biometric Authentication Technology
8. Sequencing.com to Host the Worlds First Hack the Genome Hackathon
9. The Weather Company Announces Watson Ads, To Humanize The Ad Experience for Consumers with Industry-First Capability
10. Fingerprint Cards AB (Publ.) Interim Report, First Quarter 2016
11. LegacyXChange Releases First Teaser Video Highlighting the Benefits of Its Soon to be Launched Site to the $5 Billion Worldwide Sports Collectibles Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... ... the Southeast, and its acclaimed pediatric urologists are among the professionals honored ... annual recognition signifies excellence among the country’s pediatric healthcare landscape. , Georgia ...
(Date:7/17/2019)... ... , ... At nearly eleven years old, Seve, a white Golden Retriever, began ... the last year or so, he was a little “gimpy” and occasionally his back ... VCA University Animal Hospital in Dallas, diagnosed him with severe osteoarthritis in ...
(Date:7/11/2019)... Ontario (PRWEB) , ... July ... ... of the world’s first on-site Legionella DNA test, today announced a partnership ... and hospitality industries. , Through this strategic partnership, LiquiTech will integrate Spartan’s ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... 2019 , ... Veterinary Regenerative Medicine company, VetStem Biopharma ... that their GMP facility for cell production is now approved by the California ... an important milestone for VetStem as it expands into contract cell manufacturing services. ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
(Date:5/31/2019)... Calif. (PRWEB) , ... May 30, 2019 , ... ... of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a ... The acquisition provides Object exclusive ownership and commercialization rights to a full spectrum ...
Breaking Biology Technology: